Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasculitis associated with malignancy.

L E Mertz1, D L Conn

  • 1Mayo Clinic Scottsdale, Arizona.

Current Opinion in Rheumatology
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis.

Annals of the rheumatic diseases·2008
Same author

The use of low-dose prednisone in the management of rheumatoid arthritis.

Bulletin on the rheumatic diseases·2002
Same author

Resolved: Low-dose prednisone is indicated as a standard treatment in patients with rheumatoid arthritis.

Arthritis and rheumatism·2001
Same author

Approach to the patient with suspected vasculitis.

Bulletin on the rheumatic diseases·2000
Same author

Alternative treatments and rheumatic diseases.

Bulletin on the rheumatic diseases·1999
Same author

The allure of alternative therapies.

Bulletin on the rheumatic diseases·1999
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Malignancies are rarely linked to vasculitis, which often presents with skin lesions and is associated with blood cancers. The exact cause of vasculitis in cancer patients remains unknown, with research focusing on clinical observations.

Area of Science:

  • Rheumatology and Oncology
  • Immunology and Hematology

Background:

  • Vasculopathic syndromes are infrequently associated with malignancies, with vasculitis typically manifesting as skin lesions.
  • Vasculitis in malignancy is more commonly linked to hematologic malignancies than solid tumors.
  • Evidence of immune system involvement, such as autoantibodies or immune complexes, is usually absent in malignancy-associated vasculitis.

Purpose of the Study:

  • To review the association between vasculitis and malignancies.
  • To explore the clinical characteristics and temporal relationships of vasculitis in cancer patients.
  • To highlight the current gaps in understanding the etiopathogenesis of vasculitis in the context of malignant disorders.

Main Methods:

  • Review of recent literature, focusing on case reports and small patient cohorts.

Related Experiment Videos

  • Analysis of clinical characteristics and temporal associations between malignancy and vasculitis.
  • Identification of potential complications of cancer treatments (chemotherapy, radiation, bone marrow transplantation) and mimicry of vasculitic syndromes by malignant disorders.

    • Main Results:

    • Myelodysplastic syndromes show a confident link to vasculitis based on recent literature.
    • The timing of vasculitis relative to malignancy varies, but it often follows hairy cell leukemia diagnosis and splenectomy.
    • Malignant disorders can occasionally mimic vasculitic syndromes, and vasculitis may arise as a complication of cancer therapies.

    Conclusions:

    • The etiopathogenesis of vasculitis in patients with malignant disorders is currently unknown.
    • Existing literature primarily consists of case reports and small cohorts, focusing on clinical descriptions rather than underlying mechanisms.
    • Further research is needed to elucidate the pathogenic mechanisms linking vasculitis and malignancy.